• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-196a-5p是早期舌鳞状细胞癌淋巴结转移延迟的潜在预后标志物。

MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.

作者信息

Maruyama Tessho, Nishihara Kazuhide, Umikawa Masato, Arasaki Akira, Nakasone Toshiyuki, Nimura Fumikazu, Matayoshi Akira, Takei Kimiko, Nakachi Saori, Kariya Ken-Ichi, Yoshimi Naoki

机构信息

Department of Oral and Maxillofacial Functional Rehabilitation, Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa 903-0215, Japan.

Department of Oral and Maxillofacial Surgery, University Hospital of the Ryukyus, Nishihara, Okinawa 903-0215, Japan.

出版信息

Oncol Lett. 2018 Feb;15(2):2349-2363. doi: 10.3892/ol.2017.7562. Epub 2017 Dec 8.

DOI:10.3892/ol.2017.7562
PMID:29434944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5778269/
Abstract

MicroRNAs (miRs) are expected to serve as prognostic tools for cancer. However, many miRs have been reported as prognostic markers of recurrence or metastasis in oral squamous cell carcinoma patients. We aimed to determine the prognostic markers in early-stage tongue squamous cell carcinoma (TSCC). Based on previous studies, we hypothesized that miR-10a, 10b, 196a-5p, 196a-3p, and 196b were prognostic markers and we retrospectively performed miR expression analyses using formalin-fixed paraffin-embedded sections of surgical specimens. Total RNA was isolated from cancer tissues and adjacent normal tissue as control, and samples were collected by laser-capture microdissection. After cDNA synthesis, reverse transcription-quantitative polymerase chain reaction was performed. Statistical analyses for patient clinicopathological characteristics, recurrence/metastasis, and survival rates were performed to discern their relationships with miR expression levels, and the 2 method was used. miR-196a-5p levels were significantly upregulated in early-stage TSCC, particularly in the lymph node metastasis (LNM) group. The LNM-free survival rate in the low miR-196a-5p ΔΔCq value regulation group was found to be lower than that in the high ΔΔCq value regulation group (P=0.0079). Receiver operating characteristic analysis of ΔΔCq values revealed that miR-196a-5p had a P-value=0.0025, area under the curve=0.740, and a cut-off value=-0.875 for distinguishing LNM. To our knowledge, this is the first study to examine LNM-related miRs in early-stage TSCC as well as miRs and 'delayed LNM' in head and neck cancer. miR-196a-5p upregulation may predict delayed LNM. Our data serve as a foundation for future studies to evaluate miR levels and facilitate the prediction of delayed LNM during early-stage TSCC, which prevent metastasis when combined with close follow-up and aggressive adjuvant therapy or elective neck dissection. Moreover, our data will serve as a foundation for future studies to evaluate whether miR-196a-5p can serve as a therapeutic marker for preventing metastasis.

摘要

微小RNA(miR)有望成为癌症的预后工具。然而,已有许多miR被报道为口腔鳞状细胞癌患者复发或转移的预后标志物。我们旨在确定早期舌鳞状细胞癌(TSCC)的预后标志物。基于先前的研究,我们假设miR-10a、10b、196a-5p、196a-3p和196b是预后标志物,并使用手术标本的福尔马林固定石蜡包埋切片进行了miR表达的回顾性分析。从癌组织和作为对照的相邻正常组织中分离总RNA,并通过激光捕获显微切割收集样本。合成cDNA后,进行逆转录定量聚合酶链反应。对患者的临床病理特征、复发/转移和生存率进行统计分析,以辨别它们与miR表达水平的关系,并使用2种方法。miR-196a-5p水平在早期TSCC中显著上调,尤其是在淋巴结转移(LNM)组。低miR-196a-5p ΔΔCq值调节组的无LNM生存率低于高ΔΔCq值调节组(P=0.0079)。对ΔΔCq值进行的受试者工作特征分析显示,miR-196a-5p的P值=0.0025,曲线下面积=0.740,区分LNM的截断值=-0.875。据我们所知,这是第一项研究早期TSCC中与LNM相关的miR以及头颈癌中miR和“延迟LNM”的研究。miR-196a-5p上调可能预示延迟LNM。我们的数据为未来评估miR水平以及促进早期TSCC期间延迟LNM的预测的研究奠定了基础,当与密切随访和积极的辅助治疗或选择性颈清扫相结合时可预防转移。此外,我们的数据将为未来评估miR-196a-5p是否可作为预防转移的治疗标志物的研究奠定基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e5/5778269/27d389a9ac30/ol-15-02-2349-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e5/5778269/1390b47defb0/ol-15-02-2349-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e5/5778269/00c0a658ee87/ol-15-02-2349-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e5/5778269/27d389a9ac30/ol-15-02-2349-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e5/5778269/1390b47defb0/ol-15-02-2349-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e5/5778269/00c0a658ee87/ol-15-02-2349-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e5/5778269/27d389a9ac30/ol-15-02-2349-g02.jpg

相似文献

1
MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.微小RNA-196a-5p是早期舌鳞状细胞癌淋巴结转移延迟的潜在预后标志物。
Oncol Lett. 2018 Feb;15(2):2349-2363. doi: 10.3892/ol.2017.7562. Epub 2017 Dec 8.
2
Serum miR-10a-5p and miR-196a-5p as non-invasive biomarkers in non-small cell lung cancer.血清miR-10a-5p和miR-196a-5p作为非小细胞肺癌的无创生物标志物
Int J Clin Exp Pathol. 2018 Feb 1;11(2):773-780. eCollection 2018.
3
Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.血清 microRNA 表达水平可预测早期宫颈鳞状细胞癌患者的淋巴结转移。
Int J Mol Med. 2013 Sep;32(3):557-67. doi: 10.3892/ijmm.2013.1424. Epub 2013 Jun 21.
4
Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer.微小 RNA-196a 和微小 RNA-196b 的上调与结直肠癌患者的侵袭性进展和不良预后密切相关。
Cancer Cell Int. 2014 Dec 14;14(1):128. doi: 10.1186/s12935-014-0128-2. eCollection 2014.
5
Upregulation of miRNA-196a and miRNA-196b correlates with Bryne's prognostic score in oral squamous cell carcinoma.miRNA-196a 和 miRNA-196b 的上调与口腔鳞状细胞癌中 Bryne 的预后评分相关。
Pathol Res Pract. 2024 Jan;253:154954. doi: 10.1016/j.prp.2023.154954. Epub 2023 Nov 21.
6
MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.配对的原发性和淋巴结转移性乳腺癌的MicroRNA表达谱分析揭示了与淋巴结转移相关的独特MicroRNA谱。
Front Oncol. 2020 May 19;10:756. doi: 10.3389/fonc.2020.00756. eCollection 2020.
7
Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes.mir-196a-5p在胃癌中的上调及其靶基因的KEGG通路富集分析的临床意义
Asian Pac J Cancer Prev. 2015;16(5):1781-7. doi: 10.7314/apjcp.2015.16.5.1781.
8
Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas.血浆外泌体miR-146b-5p和miR-222-3p是甲状腺乳头状癌淋巴结转移的潜在生物标志物。
Onco Targets Ther. 2020 Feb 13;13:1311-1319. doi: 10.2147/OTT.S231361. eCollection 2020.
9
Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas.血清中微小RNA-196a和微小RNA-196b的联合升高预示骨肉瘤患者预后不良。
Int J Mol Sci. 2014 Apr 17;15(4):6544-55. doi: 10.3390/ijms15046544.
10
microRNA Profile Associated with Positive Lymph Node Metastasis in Early-Stage Cervical Cancer.早期宫颈癌中与阳性淋巴结转移相关的 microRNA 谱。
Curr Oncol. 2022 Jan 8;29(1):243-254. doi: 10.3390/curroncol29010023.

引用本文的文献

1
Smoking and alcohol specific alterations in miRNA expression in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中miRNA表达的吸烟和酒精特异性改变
Discov Oncol. 2025 Aug 2;16(1):1458. doi: 10.1007/s12672-025-03308-2.
2
Evaluating fusion models for predicting occult lymph node metastasis in tongue squamous cell carcinoma.评估用于预测舌鳞状细胞癌隐匿性淋巴结转移的融合模型。
Eur Radiol. 2025 Mar 5. doi: 10.1007/s00330-025-11473-9.
3
Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma.血清 CXCL13 作为口腔鳞状细胞癌的一种新型生物标志物。

本文引用的文献

1
Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods.通过使用非侵入性方法提高口腔癌基于RNA的诊断和预后准确性。
Oral Oncol. 2017 Jun;69:62-67. doi: 10.1016/j.oraloncology.2017.04.001. Epub 2017 Apr 17.
2
miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis.微小RNA-10a通过调节上皮-间质转化和失巢凋亡来抑制结直肠癌转移。
Cell Death Dis. 2017 Apr 6;8(4):e2739. doi: 10.1038/cddis.2017.61.
3
Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
Cancer Med. 2024 Sep;13(18):e70263. doi: 10.1002/cam4.70263.
4
MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis.miRNA 表达作为舌鳞状细胞癌 (TSCC) 的预后生物标志物:系统评价和荟萃分析。
BMC Oral Health. 2024 Mar 31;24(1):406. doi: 10.1186/s12903-024-04182-0.
5
miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology.头颈部鳞状细胞癌中的微小RNA:个性化肿瘤学前景光明但仍任重道远
Rep Pract Oncol Radiother. 2023 Nov 16;28(5):681-697. doi: 10.5603/rpor.96666. eCollection 2023.
6
The Potential microRNA Prognostic Signature in HNSCCs: A Systematic Review.头颈部鳞状细胞癌中潜在的微小RNA预后标志物:一项系统评价
Noncoding RNA. 2023 Sep 14;9(5):54. doi: 10.3390/ncrna9050054.
7
Potential Role of miR-196a and miR-196b as Prognostic Biomarkers of Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis and Trial Sequential Analysis.miR-196a和miR-196b作为头颈部鳞状细胞癌生存预后生物标志物的潜在作用:一项系统评价、荟萃分析和试验序贯分析
Life (Basel). 2022 Aug 19;12(8):1269. doi: 10.3390/life12081269.
8
Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma.鉴定差异表达的 microRNAs 作为癌型多形性腺瘤的潜在生物标志物。
Sci Rep. 2022 Aug 4;12(1):13383. doi: 10.1038/s41598-022-17740-9.
9
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.头颈部癌症中有前景的生物标志物:最具临床意义的 miRNAs。
Int J Mol Sci. 2022 Jul 26;23(15):8257. doi: 10.3390/ijms23158257.
10
circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-β/Smad and EGFR pathways.环状MTO1通过TGF-β/Smad和EGFR途径吸附微小RNA-219a-5p以促进胆囊癌进展。
Oncol Lett. 2021 Jul;22(1):563. doi: 10.3892/ol.2021.12824. Epub 2021 May 27.
治疗前低淋巴细胞-单核细胞比率和高血小板-淋巴细胞比率提示早期舌癌患者预后不良。
J Oral Maxillofac Surg. 2017 Aug;75(8):1762-1774. doi: 10.1016/j.joms.2016.12.023. Epub 2016 Dec 26.
4
MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer.微小RNA-221,一种甲状腺乳头状癌复发的潜在预后生物标志物。
World J Surg Oncol. 2017 Jan 7;15(1):11. doi: 10.1186/s12957-016-1086-z.
5
Predictive markers for delayed lymph node metastases and survival in early-stage oral squamous cell carcinoma.早期口腔鳞状细胞癌中延迟性淋巴结转移和生存的预测标志物。
Head Neck. 2017 Apr;39(4):694-701. doi: 10.1002/hed.24667. Epub 2016 Dec 22.
6
Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma.活检标本中评估的肿瘤芽生是cN0早期口腔鳞状细胞癌患者预后的有用预测指标。
Histopathology. 2017 May;70(6):869-879. doi: 10.1111/his.13144. Epub 2017 Feb 16.
7
Neck dissection versus "watchful-waiting" in early squamous cell carcinoma of the tongue our experience on 127 cases.舌早期鳞状细胞癌行颈淋巴结清扫术与“观察等待”的比较:我们对127例患者的经验
Surg Oncol. 2016 Dec;25(4):401-404. doi: 10.1016/j.suronc.2016.09.005. Epub 2016 Sep 21.
8
Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.miR-376c 下调导致 RUNX2/Activin-A 轴失调促进头颈部鳞状细胞癌淋巴结转移。
Cancer Res. 2016 Dec 15;76(24):7140-7150. doi: 10.1158/0008-5472.CAN-16-1188. Epub 2016 Oct 19.
9
The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis.微小RNA-196a在肿瘤发生、肿瘤进展及预后中的作用。
Tumour Biol. 2016 Dec;37:15457–15466. doi: 10.1007/s13277-016-5430-2. Epub 2016 Oct 18.
10
Oral cancer: Deregulated molecular events and their use as biomarkers.口腔癌:失调的分子事件及其作为生物标志物的应用。
Oral Oncol. 2016 Oct;61:12-8. doi: 10.1016/j.oraloncology.2016.07.013. Epub 2016 Aug 3.